Interim Analysis Started for A021501 New treatment options are available for patients with borderline resectable pancreatic cancer. Exciting research is underway by the Alliance to help to improve the care of patients with previously unresectable pancreatic cancer. The Alliance recent
Change in Trial Status: Interim Analysis Started for Alliance Borderline Resectable Pancreatic Cancer Trial
